A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL
Status:
Completed
Trial end date:
2018-01-15
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety of the study drug known as LY3039478
in combination with dexamethasone in participants with T-cell acute lymphoblastic leukemia or
T-cell lymphoblastic lymphoma (T-ALL/T-LBL).